# ClinicalTrials.gov record NCT04081337

> PeptideScanner retained ClinicalTrials.gov record NCT04081337 at 2026-07-30T18:48:25.645Z. Its registry update date was 2024-02-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct04081337-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-02-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04081337-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04081337-tirzepatide-v1.json
- Content SHA-256: `8214b5f72d28533f4dac462b150b29f75f8431e03be85807ebb2fac44408ba1d`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04081337 ([`ctg-observation-nct04081337-2024-02-08-de8b30f54424`](#source-ctg-observation-nct04081337-2024-02-08-de8b30f54424))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04081337 at 2026-07-30T18:48:25.645Z. Its registry update date was 2024-02-08, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct04081337-2024-02-08-de8b30f54424`](#source-ctg-observation-nct04081337-2024-02-08-de8b30f54424))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04081337 at 2026-07-30T18:48:25.645Z. Its registry update date was 2024-02-08, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct04081337-2024-02-08-de8b30f54424`](#source-ctg-observation-nct04081337-2024-02-08-de8b30f54424))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04081337-2024-02-08-de8b30f54424`](#source-ctg-observation-nct04081337-2024-02-08-de8b30f54424))

## Sources

<a id="source-ctg-observation-nct04081337-2024-02-08-de8b30f54424"></a>
- **ClinicalTrials.gov record NCT04081337 · retained source version 2024-02-08:de8b30f54424c2c8bc007576bcc007c02fbef58223386c10d10466ed596dee92** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04081337) (`ctg-observation-nct04081337-2024-02-08-de8b30f54424`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04081337." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04081337-tirzepatide-v1.json SHA-256: 8214b5f72d28533f4dac462b150b29f75f8431e03be85807ebb2fac44408ba1d.